By Dean Seal
Shares of CVS Health jumped after the company reported a strong first quarter and agreed to open up access to Novo Nordisk's weight-loss medication at more affordable prices.
The stock was up 8.7% at $72.51 ahead of the opening bell, putting them on track for a 52-week high. Shares were trading at $56.31 this time a year ago.
The healthcare heavyweight said Thursday that its pharmacy-benefit manager CVS Caremark has partnered with the Danish drugmaker Novo Nordisk and will start giving preference to Wegovy for its members starting on July 1.
The company also reported adjusted earnings of $2.25 a share on $94.59 billion in revenue for the first quarter. Analysts polled by FactSet had been expecting $1.70 a share on $93.66 billion in revenue.
The top line grew from increases in its Medicare line, including better Medicare Advantage star ratings for 2025, the company said.
CVS said it plans to exit the individual exchange business in which Aetna independently operates Affordable Care Act plans for 2026.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
May 01, 2025 09:20 ET (13:20 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。